Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 199

The DOI matches its Crossref record.

Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma

Open access
Kari, Laszlo, Loboda, Andrey, Nebozhyn, Michael, Rook, Alain H., Vonderheid, Eric C., Nichols, Calen, Virok, Dezso, Chang, Celia, Horng, Wen-Hwai, Johnston, James, Wysocka, Maria, Showe, Michael K., Showe, Louise C. · 2003 · The Journal of Experimental Medicine

Abstract

We have used cDNA arrays to investigate gene expression patterns in peripheral blood mononuclear cells from patients with leukemic forms of cutaneous T cell lymphoma, primarily Sezary syndrome (SS). When expression data for patients with high blood tumor burden (Sezary cells >60% of the lymphocytes) and healthy controls are compared by Student's t test, at P < 0.01, we find 385 genes to be differentially expressed. Highly overexpressed genes include Th2 cells–specific transcription factors Gata-3 and Jun B, as well as integrin β1, proteoglycan 2, the RhoB oncogene, and dual specificity phosphatase 1. Highly underexpressed genes include CD26, Stat-4, and the IL-1 receptors. Message for plastin-T, not normally expressed in lymphoid tissue, is detected only in patient samples and may provide a new marker for diagnosis. Using penalized discriminant analysis, we have identified a panel of eight genes that can distinguish SS in patients with as few as 5% circulating tumor cells. This suggests that, even in early disease, Sezary cells produce chemokines and cytokines that induce an expression profile in the peripheral blood distinctive to SS. Finally, we show that using 10 genes, we can identify a class of patients who will succumb within six months of sampling regardless of their tumor burden.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20021726

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 199

Metadata

Authors
Kari, L., Loboda, A., Nebozhyn, M., Rook, A. H., Vonderheid, E. C., Nichols, C., Virok, D., Chang, C., Horng, W.-H., Johnston, J., Wysocka, M., Showe, M. K., & Showe, L. C.
Venue
The Journal of Experimental Medicine
Published
2003-06-02
Volume
197
Issue
11
Pages
1477-1488
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2101208734
Cited by
199
References
0
FWCI
18.29
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma. https://app.cochat.ai/papers/10.1084/jem.20021726
The paper
Kari, L., Loboda, A., Nebozhyn, M., Rook, A. H., Vonderheid, E. C., Nichols, C., Virok, D., Chang, C., Horng, W.-H., Johnston, J., Wysocka, M., Showe, M. K., & Showe, L. C. (2003). Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma. The Journal of Experimental Medicine. https://doi.org/10.1084/jem.20021726

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.